Login Register Cart 0
Generic placeholder image

Current Neurovascular Research

Editor-in-Chief

ISSN (Print): 1567-2026
ISSN (Online): 1875-5739

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Association between HbA1C (Glycated Hemoglobin) and Clinical Outcomes in Patients with Subarachnoid Hemorrhage After Neuro-intervention

Author(s): Chan W. Park , Ho J. Yi*, Dong H. Lee and Jae H. Sung

Volume 18, Issue 1, 2021

Published on: 25 February, 2021

Page: [93 - 101] Pages: 9

DOI: 10.2174/1567202618666210225103057

Price: $65

Abstract

Objective: Our study investigated the association between the level of HbA1c (glycated hemoglobin) at admission and the prognosis of aneurysmal subarachnoid hemorrhage (SAH).

Methods: A total of 510 patients treated with neuro-intervention for aneurysmal SAH and with data for admission HbA1c (glycated hemoglobin) were included. Favorable clinical outcome was defined as modified Rankin Scale (mRS) score of 0-2 at 3 months. Receiver operating characteristic (ROC) curve analysis was used to identify the optimal cutoff value of HbA1C for unfavorable clinical outcomes. Logistic regression was used to evaluate the association between HbA1C level and outcomes.

Results: The optimal cutoff value of HbA1C was identified as 6.0% (P < 0.001), and patients with a high HbA1C (≥ 6.0%) had a lower prevalence of favorable clinical outcomes than patients with low HbA1C (< 6.0%) (P < 0.001). High HbA1C (≥ 6.0%) was independently associated with unfavorable clinical outcome (OR 2.84; 95% CI: 1.52-5.44; P = 0.004). The risk of unfavorable clinical outcome was significantly increased in patients with HbA1C (≥ 7.0%, < 8%) and HbA1C (≥ 8.0%) compared with lower baseline HbA1C (≥ 6.0%, < 7%) values (OR 2.17; 95% CI: 1.87-5.13; P = 0.011 and OR 4.25; 95% CI: 3.17-8.41; P = 0.005).

Conclusion: Our study showed that HbA1C could be an independent predictor of worse outcomes following neuro-intervention for aneurysmal SAH. High HbA1C (≥ 6.0%) was associated with unfavorable clinical outcomes, and gradual elevation of HbA1C contributed to an increase in the risk of worse clinical outcomes after SAH.

Keywords: Aneurysm, glucose, glycated hemoglobin, hyperglycemia, subarachnoid hemorrhage, HbA1C.

« Previous Next »
[1]
Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: A systematic review. Lancet Neurol 2009; 8(4): 355-69.
[http://dx.doi.org/10.1016/S1474-4422(09)70025-0] [PMID: 19233729]
[2]
Passier PE, Visser-Meily JM, Rinkel GJ, Lindeman E, Post MW. Life satisfaction and return to work after aneurysmal subarachnoid hemorrhage. J Stroke Cerebrovasc Dis 2011; 20(4): 324-9.
[http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2010.02.001] [PMID: 20656515]
[3]
Zhang JM. [Guidelines for diagnosis and management of aneurysmal subarachnoid hemorrhage: Top issues and prospective]. Zhejiang Da Xue Xue Bao Yi Xue Ban 2015; 44(4): 357-60.
[PMID: 26555410]
[4]
Feigin VL, Rinkel GJ, Lawes CM, et al. Risk factors for subarachnoid hemorrhage: An updated systematic review of epidemiological studies. Stroke 2005; 36(12): 2773-80.
[http://dx.doi.org/10.1161/01.STR.0000190838.02954.e8] [PMID: 16282541]
[5]
Mijiti M, Mijiti P, Axier A, et al. Incidence and predictors of angiographic vasospasm, symptomatic vasospasm and cerebral infarction in chinese patients with aneurysmal subarachnoid hemorrhage. PLoS One 2016; 11(12): e0168657.
[http://dx.doi.org/10.1371/journal.pone.0168657] [PMID: 27977801]
[6]
Rosengart AJ, Schultheiss KE, Tolentino J, Macdonald RL. Prognostic factors for outcome in patients with aneurysmal subarachnoid hemorrhage. Stroke 2007; 38(8): 2315-21.
[http://dx.doi.org/10.1161/STROKEAHA.107.484360] [PMID: 17569871]
[7]
AlMatter M, Aguilar Péreza M, Bhogal P, Hellstern V, Ganslandt O, Henkes H. Results of interdisciplinary management of 693 patients with aneurysmal subarachnoid hemorrhage: Clinical outcome and relevant prognostic factors. Clin Neurol Neurosurg 2018; 167: 106-11.
[http://dx.doi.org/10.1016/j.clineuro.2018.02.022] [PMID: 29475026]
[8]
Beseoglu K, Steiger HJ. Elevated glycated hemoglobin level and hyperglycemia after aneurysmal subarachnoid hemorrhage. Clin Neurol Neurosurg 2017; 163: 128-32.
[http://dx.doi.org/10.1016/j.clineuro.2017.10.037] [PMID: 29101862]
[9]
Kruyt ND, Biessels GJ, DeVries JH, et al. Hyperglycemia in aneurysmal subarachnoid hemorrhage: A potentially modifiable risk factor for poor outcome. J Cereb Blood Flow Metab 2010; 30(9): 1577-87.
[http://dx.doi.org/10.1038/jcbfm.2010.102] [PMID: 20628402]
[10]
Béjot Y, Aboa-Eboulé C, Hervieu M, et al. The deleterious effect of admission hyperglycemia on survival and functional outcome in patients with intracerebral hemorrhage. Stroke 2012; 43(1): 243-5.
[http://dx.doi.org/10.1161/STROKEAHA.111.632950] [PMID: 21940959]
[11]
Godoy DA, Di Napoli M. Hyperglycemia in acute phase of spontaneous intracerebral hemorrhage (sICH). J Neurol Sci 2007; 263(1-2): 228-9.
[http://dx.doi.org/10.1016/j.jns.2007.06.020] [PMID: 17663002]
[12]
Guo X, Li H, Zhang Z, et al. Hyperglycemia and mortality risk in patients with primary intracerebral hemorrhage: A meta-analysis. Mol Neurobiol 2016; 53(4): 2269-75.
[http://dx.doi.org/10.1007/s12035-015-9184-4] [PMID: 25972238]
[13]
Zheng D, Zhao X. Intensive versus standard glucose control in patients with ischemic stroke: A meta-analysis of randomized controlled trials. World Neurosurg 2020; 136: e487-95.
[http://dx.doi.org/10.1016/j.wneu.2020.01.042] [PMID: 31954885]
[14]
Kruyt ND, Biessels GJ, de Haan RJ, et al. Hyperglycemia and clinical outcome in aneurysmal subarachnoid hemorrhage: A meta-analysis. Stroke 2009; 40(6): e424-30.
[http://dx.doi.org/10.1161/STROKEAHA.108.529974] [PMID: 19390078]
[15]
Huang YH, Chung CL, Tsai HP, et al. Hyperglycemia aggravates cerebral vasospasm after subarachnoid hemorrhage in a rat model. Neurosurgery 2017; 80(5): 809-15.
[http://dx.doi.org/10.1093/neuros/nyx016] [PMID: 28379540]
[16]
Dorhout Mees SM, van Dijk GW, Algra A, Kempink DR, Rinkel GJ. Glucose levels and outcome after subarachnoid hemorrhage. Neurology 2003; 61(8): 1132-3.
[http://dx.doi.org/10.1212/01.WNL.0000090466.68866.02] [PMID: 14581680]
[17]
Frontera JA, Fernandez A, Schmidt JM, et al. Defining vasospasm after subarachnoid hemorrhage: What is the most clinically relevant definition? Stroke 2009; 40(6): 1963-8.
[http://dx.doi.org/10.1161/STROKEAHA.108.544700] [PMID: 19359629]
[18]
Ray B, Ludwig A, Yearout LK, Thompson DM, Bohnstedt BN. Stress-induced hyperglycemia after spontaneous subarachnoid hemorrhage and its role in predicting cerebrospinal fluid diversion. World Neurosurg 2017; 100: 208-15.
[http://dx.doi.org/10.1016/j.wneu.2017.01.008] [PMID: 28089808]
[19]
Hendryk S, Jarzab B, Josko J. Increase of the IL-1 beta and IL-6 levels in CSF in patients with vasospasm following aneurysmal SAH. Neuroendocrinol Lett 2004; 25(1-2): 141-7.
[PMID: 15159698]
[20]
Larysz-Brysz M, Lewin-Kowalik J, Czuba Z, et al. Interleukin-1β increases release of endothelin-1 and tumor necrosis factor as well as reactive oxygen species by peripheral leukocytes during experimental subarachnoid hemorrhage. Curr Neurovasc Res 2012; 9(3): 159-66.
[http://dx.doi.org/10.2174/156720212801619045] [PMID: 22621234]
[21]
Lv SY, Wu Q, Liu JP, et al. Levels of interleukin-1β, interleukin-18, and tumor necrosis factor-α in cerebrospinal fluid of aneurysmal subarachnoid hemorrhage patients may be predictors of early brain injury and clinical prognosis. World Neurosurg 2018; 111: e362-73.
[http://dx.doi.org/10.1016/j.wneu.2017.12.076] [PMID: 29277532]
[22]
Lyons TJ, Basu A. Biomarkers in diabetes: Hemoglobin A1C, vascular and tissue markers. Transl Res 2012; 159(4): 303-12.
[http://dx.doi.org/10.1016/j.trsl.2012.01.009] [PMID: 22424433]
[23]
Nathan DM, Turgeon H, Regan S. Relationship between glycated haemoglobin levels and mean glucose levels over time. Diabetologia 2007; 50(11): 2239-44.
[http://dx.doi.org/10.1007/s00125-007-0803-0] [PMID: 17851648]
[24]
Vergouwen MD, Vermeulen M, van Gijn J, et al. Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: Proposal of a multidisciplinary research group. Stroke 2010; 41(10): 2391-5.
[http://dx.doi.org/10.1161/STROKEAHA.110.589275] [PMID: 20798370]
[25]
Crowley RW, Medel R, Dumont AS, et al. Angiographic vasospasm is strongly correlated with cerebral infarction after subarachnoid hemorrhage. Stroke 2011; 42(4): 919-23.
[http://dx.doi.org/10.1161/STROKEAHA.110.597005] [PMID: 21350201]
[26]
Hackett ML, Anderson CS. Health outcomes 1 year after subarachnoid hemorrhage: An international population-based study. Neurology 2000; 55(5): 658-62.
[http://dx.doi.org/10.1212/WNL.55.5.658] [PMID: 10980729]
[27]
Lawton MT, Vates GE. Subarachnoid Hemorrhage. N Engl J Med 2017; 377(3): 257-66.
[http://dx.doi.org/10.1056/NEJMcp1605827] [PMID: 28723321]
[28]
Fu C, Yu W, Sun L, Li D, Zhao C. Early cerebral infarction following aneurysmal subarachnoid hemorrhage: Frequency, risk factors, patterns, and prognosis. Curr Neurovasc Res 2013; 10(4): 316-24.
[http://dx.doi.org/10.2174/15672026113109990027] [PMID: 24016219]
[29]
Zheng Z, Sanchez-Porras R, Santos E, Unterberg AW, Sakowitz OW. Delayed cerebral ischemia after subarachnoid hemorrhage: From vascular spasm to cortical spreading depolarizations. Curr Neurovasc Res 2012; 9(4): 310-9.
[http://dx.doi.org/10.2174/156720212803530663] [PMID: 22873726]
[30]
Alberti O, Becker R, Benes L, Wallenfang T, Bertalanffy H. Initial hyperglycemia as an indicator of severity of the ictus in poor-grade patients with spontaneous subarachnoid hemorrhage. Clin Neurol Neurosurg 2000; 102(2): 78-83.
[http://dx.doi.org/10.1016/S0303-8467(00)00067-6] [PMID: 10817893]
[31]
Frontera JA, Fernandez A, Claassen J, et al. Hyperglycemia after SAH: Predictors, associated complications, and impact on outcome. Stroke 2006; 37(1): 199-203.
[http://dx.doi.org/10.1161/01.STR.0000194960.73883.0f] [PMID: 16339481]
[32]
Kruyt ND, Roos YW, Dorhout Mees SM, et al. High mean fasting glucose levels independently predict poor outcome and delayed cerebral ischaemia after aneurysmal subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 2008; 79(12): 1382-5.
[http://dx.doi.org/10.1136/jnnp.2007.142034] [PMID: 18403438]
[33]
Badjatia N, Topcuoglu MA, Buonanno FS, et al. Relationship between hyperglycemia and symptomatic vasospasm after subarachnoid hemorrhage. Crit Care Med 2005; 33(7): 1603-9.
[http://dx.doi.org/10.1097/01.CCM.0000168054.60538.2B] [PMID: 16003069]
[34]
Charpentier C, Audibert G, Guillemin F, et al. Multivariate analysis of predictors of cerebral vasospasm occurrence after aneurysmal subarachnoid hemorrhage. Stroke 1999; 30(7): 1402-8.
[http://dx.doi.org/10.1161/01.STR.30.7.1402] [PMID: 10390314]
[35]
McGirt MJ, Woodworth GF, Ali M, Than KD, Tamargo RJ, Clatterbuck RE. Persistent perioperative hyperglycemia as an independent predictor of poor outcome after aneurysmal subarachnoid hemorrhage. J Neurosurg 2007; 107(6): 1080-5.
[http://dx.doi.org/10.3171/JNS-07/12/1080] [PMID: 18077943]
[36]
Murata GH, Hoffman RM, Duckworth WC, Wendel CS, Shah JH. Contributions of weekly mean blood glucose values to hemoglobin A1c in insulin-treated type 2 diabetes: The diabetes outcomes in veterans study (DOVES). Am J Med Sci 2004; 327(6): 319-23.
[http://dx.doi.org/10.1097/00000441-200406000-00004] [PMID: 15201644]
[37]
Parmar MS, Syed I, Gray JP, Ray SD. Curcumin, hesperidin, and rutin selectively interfere with apoptosis signaling and attenuate streptozotocin-induced oxidative stress-mediated hyperglycemia. Curr Neurovasc Res 2015; 12(4): 363-74.
[http://dx.doi.org/10.2174/1567202612666150812150249] [PMID: 26265154]
[38]
Luitse MJ, Biessels GJ, Rutten GE, Kappelle LJ. Diabetes, hyperglycaemia, and acute ischaemic stroke. Lancet Neurol 2012; 11(3): 261-71.
[http://dx.doi.org/10.1016/S1474-4422(12)70005-4] [PMID: 22341034]
[39]
Choi KH, Kim JH, Kang KW, et al. HbA1c (Glycated Hemoglobin) levels and clinical outcome post-mechanical thrombectomy in patients with large vessel occlusion. Stroke 2018; 2018: A118021598.
[PMID: 30580713]
[40]
Shukla V, Shakya AK, Perez-Pinzon MA, Dave KR. Cerebral ischemic damage in diabetes: An inflammatory perspective. J Neuroinflammation 2017; 14(1): 21.
[http://dx.doi.org/10.1186/s12974-016-0774-5] [PMID: 28115020]
[41]
Kim JG, Yi HJ, Lee DH, Sung JH. Impact of HbA1C (Glycated Hemoglobin) and glucose on outcomes of mechanical thrombectomy in patients with large artery occlusion. Curr Neurovasc Res 2020; 17(4): 376-84.
[http://dx.doi.org/10.2174/1567202617666200514115446] [PMID: 32407278]
[42]
Wang L, Zhou Z, Tian X, et al. Impact of relative blood glucose changes on mortality risk of patient with acute ischemic stroke and treated with mechanical thrombectomy. J Stroke Cerebrovasc Dis 2019; 28(1): 213-9.
[http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2018.09.036] [PMID: 30539756]
[43]
Diprose WK, Wang MTM, McFetridge A, Sutcliffe J, Barber PA. Glycated hemoglobin (HbA1c) and outcome following endovascular thrombectomy for ischemic stroke. J Neurointerv Surg 2020; 12(1): 30-2.
[http://dx.doi.org/10.1136/neurintsurg-2019-015023] [PMID: 31147437]
[44]
Masrur S, Cox M, Bhatt DL, et al. Association of acute and chronic hyperglycemia with acute ischemic stroke outcomes post-thrombolysis: Findings from get with the guidelines-stroke. J Am Heart Assoc 2015; 4(10): e002193.
[http://dx.doi.org/10.1161/JAHA.115.002193] [PMID: 26408015]
[45]
Rocco A, Heuschmann PU, Schellinger PD, et al. Glycosylated hemoglobin A1 predicts risk for symptomatic hemorrhage after thrombolysis for acute stroke. Stroke 2013; 44(8): 2134-8.
[http://dx.doi.org/10.1161/STROKEAHA.111.675918] [PMID: 23715962]
[46]
Saliba W, Barnett-Griness O, Gronich N, et al. Association of diabetes and glycated hemoglobin with the risk of intracerebral hemorrhage: A population-based cohort study. Diabetes Care 2019; 42(4): 682-8.
[http://dx.doi.org/10.2337/dc18-2472] [PMID: 30728223]
[47]
Chen YS, Lian LF, Xu YH, et al. [Association of glycosylated hemoglobin level at admission with outcomes of intracerebral hemorrhage patients]. Zhonghua Liu Xing Bing Xue Za Zhi 2019; 40(11): 1445-9.
[PMID: 31838819]
[48]
Can A, Castro VM, Yu S, et al. Antihyperglycemic agents are inversely associated with intracranial aneurysm rupture. Stroke 2018; 49(1): 34-9.
[http://dx.doi.org/10.1161/STROKEAHA.117.019249] [PMID: 29203688]

Rights & Permissions Print Cite
Article Metrics
52
1
© 2024 Bentham Science Publishers | Privacy Policy